Literature DB >> 32303348

Influence of hospital teaching status on the chance to achieve a textbook outcome after hepatopancreatic surgery for cancer among Medicare beneficiaries.

Rittal Mehta1, Anghela Z Paredes1, Diamantis I Tsilimigras1, Amika Moro1, Kota Sahara1, Ayesha Farooq1, Mary Dillhoff1, Jordan M Cloyd1, Allan Tsung1, Aslam Ejaz1, Timothy M Pawlik2.   

Abstract

BACKGROUND: Assessing composite measures of quality such as textbook outcome may be superior to focusing on individual parameters when evaluating hospital performance. The aim of the current study was to assess the impact of teaching hospital status on the occurrence of a textbook outcome after hepatopancreatic surgery.
METHODS: The Medicare Inpatient Standard Analytic Files were used to identify patients undergoing hepatopancreatic surgery from 2013 to 2015 for a malignant indication. Stratified and multivariable regression analyses were performed to determine the relationship between teaching hospital status, hospital surgical volume and textbook outcome.
RESULTS: Among 8,035 Medicare patients (hepatectomy; 41.8%, pancreatectomy; 58.2%), 6,196 (77.1%) patients underwent surgery at a major teaching hospital, whereas 1,839 (22.9%) patients underwent surgery at a minor teaching hospital. Patients undergoing surgery for pancreatic cancer at a major teaching hospital had a greater likelihood of achieving a textbook outcome compared with patients treated at a minor teaching hospital (minor teaching hospital: 456, 40% versus major teaching hospital: 1,606, 45.4%; P = .002). The likelihood of textbook outcome was also greater among patients undergoing hepatopancreatic surgery at high-volume centers (pancreas, low volume: 875, 40.5% versus high volume: 1,187, 47.1% P < .001; liver, low volume: 608, 41.8% versus high volume: 886, 46.6%; P = .005). When examining only major teaching hospitals, patients undergoing a pancreatectomy at a high-volume center had 29% greater odds of achieving a textbook outcome (odds ratio 1.29, 95% confidence interval 1.12-1.49). In contrast, among patients undergoing pancreatic resection at high-volume centers, the odds of achieving a textbook outcome was comparable among major versus minor teaching hospital (odds ratio 1.17, 95% confidence interval 0.89-1.53).
CONCLUSION: The odds of achieving a textbook outcome after pancreatic and hepatic surgery was greater at major versus minor teaching hospitals; however, this effect was largely mediated by hepatopancreatic procedural volume. Patients and payers should focus on regionalization of pancreatic and liver resection to high-volume centers in an effort to optimize the chances of achieving a textbook outcome.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32303348     DOI: 10.1016/j.surg.2020.02.024

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy.

Authors:  Alessandro Paro; Diamantis I Tsilimigras; Djhenne Dalmacy; Rayyan S Mirdad; J Madison Hyer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-02-05       Impact factor: 3.452

2.  Impact of Residential Racial Integration on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Resection for Cancer.

Authors:  Alessandro Paro; Djhenne Dalmacy; J Madison Hyer; Diamantis I Tsilimigras; Adrian Diaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-04-24       Impact factor: 5.344

3.  Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study.

Authors:  Sivesh K Kamarajah; Samer A Naffouje; George I Salti; Fadi S Dahdaleh
Journal:  Ann Surg Oncol       Date:  2021-01-04       Impact factor: 5.344

4.  Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma - definitions and influencing factors.

Authors:  Christian Benzing; Lena Marie Haiden; Felix Krenzien; Alexa Mieg; Annika Wolfsberger; Cecilia Filiz Atik; Nora Nevermann; Uli Fehrenbach; Wenzel Schöning; Moritz Schmelzle; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2022-03-04       Impact factor: 2.895

5.  Textbook outcomes in hepatobiliary and pancreatic surgery.

Authors:  Diamantis I Tsilimigras; Timothy Michael Pawlik; Dimitrios Moris
Journal:  World J Gastroenterol       Date:  2021-04-21       Impact factor: 5.742

6.  Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis.

Authors:  Qiyue Chen; Zhongliang Ning; Zhiyu Liu; Yanbing Zhou; Qingliang He; Yantao Tian; Hankun Hao; Wei Lin; Lixin Jiang; Gang Zhao; Ping Li; Chaohui Zheng; Changming Huang
Journal:  Chin J Cancer Res       Date:  2021-08-31       Impact factor: 5.087

7.  Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.

Authors:  Sivesh K Kamarajah; Ewen A Griffiths; Alexander W Phillips; Jelle Ruurda; Richard van Hillegersberg; Wayne L Hofstetter; Sheraz R Markar
Journal:  Ann Surg Oncol       Date:  2021-12-10       Impact factor: 5.344

8.  ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery.

Authors:  Sivesh K Kamarajah; Ewen A Griffiths; Alexander W Phillips; Jelle Ruurda; Richard van Hillegersberg; Wayne L Hofstetter; Sheraz R Markar
Journal:  Ann Surg Oncol       Date:  2021-11-27       Impact factor: 5.344

9.  Association of County-Level Racial Diversity and Likelihood of a Textbook Outcome Following Pancreas Surgery.

Authors:  Adrian Diaz; Djhenne Dalmacy; Chelsea Herbert; Rayyan S Mirdad; J Madison Hyer; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-06-18       Impact factor: 5.344

10.  Patient Perspectives on Defining Textbook Outcomes Following Major Abdominal Surgery.

Authors:  Jason T Wiseman; Angela Sarna; Celia E Wills; Joal Beane; Valerie Grignol; Aslam Ejaz; Timothy M Pawlik; Naruhiko Ikoma; Jordan M Cloyd
Journal:  J Gastrointest Surg       Date:  2021-07-29       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.